Skip to content

The Role of Cycling-cognitive Dual-task Training in Early Parkinson's Disease

The Role of Cycling-cognitive Dual-task Training in Early Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04114318
Enrollment
26
Registered
2019-10-03
Start date
2016-06-01
Completion date
2017-05-31
Last updated
2019-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Safety and Effectiveness

Brief summary

The purpose of the study will investigate the safety and effectiveness with eight-week cycling-cognitive dual-task training for early Parkinson's disease.

Detailed description

Background: Parkinson's disease is a neurodegenerative disorder of the basal ganglia in which the production of dopamine is reduced, leading to the motor and non-motor impairment and the loss of automaticity. Recently, the results across studies have indicated that motor-cognitive dual-task deficits in individuals with neurologic disorders appear to be amenable to training. Improvement of dual-task ability in individuals with neurologic disorders holds potential for improving gait, balance, and cognition. The most recent European guideline provides a more graded view, stating that in Hoehn and Yahr stages 2 and 3 dual-task training may be safe and effective. An overview of current ongoing randomized controlled trials focusing on dual-task rehabilitation, gait training or treadmill training was the major motor-task. However, cycling augmented by cognitive training has not been evaluated. In addition, antioxidant capacity is unclear for Parkinson's disease patients with long-term, regular cycling training. Study purpose: The purpose of the study will investigate the safety and effectiveness with eight-week cycling-cognitive dual-task training for early Parkinson's disease. The antioxidant capacity will be assessed as well. Methods: Parkinson's disease patients will be assigned to cycling training, cycling-cognitive dual task training, and following 8 weeks. All of the subjects will complete 3 assessments at pre-training, post-4 weeks, and post-8 weeks. The outcome measures are clinical severity and disability, performance of gait-cognitive and cycling-cognitive, cognitive-task performance, peripheral-blood oxidative stress, adverse events, etc. Significance: In this study, evidence-based practice as the foundation, and perspective to design a safe and effective cycling-cognitive dual-task training for early Parkinson's disease. It can be verified in the clinical application of these experiments feasibility (practice-based evidence).

Interventions

OTHERDual-task cognitive-cycling training

Cognitive and cycling training simultaneously for dual-task cognitive-cycling training; stationary bicycle exercise training for single-task cycling training

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* patients with Idiopathic Parkinson's disease (IPD) * an age between 45 to 70 years * asymmetrical onset of at least 2 of 3 cardinal sign * Modified Hoehn and Yahr staging from 1 to 2.5 during off state * Montreal cognitive assessment score of 26 or greater

Exclusion criteria

The patients were ineligible if they had * a neurological history other than Parkinson's disease * ever undergone neurosurgery for Parkinson's disease * had moderate to severe dyskinesia * been unstable with medical or psychiatric co-morbidities, orthopedic conditions restricting exercise * done more than 20 min of aerobic exercise over 3 sessions per week on their own

Design outcomes

Primary

MeasureTime frameDescription
Unified Parkinson's disease rating scale30 minutesThere are 4 parts subscores: part 1 (0-16), part 2 (0-52), part 3 (0-96), part 4 (0-23). Total scale range 0-187 (summed part 1, 2, 3, 4), higher values represent a worse outcome.
Gait speed in cm/second5 minutesusing GAITRite with a 3.66-meter long and 0.9-meter wide instrumented walkway
Step length in cm5 minutesusing GAITRite with a 3.66-meter long and 0.9-meter wide instrumented walkway
Step width in cm5 minutesusing GAITRite with a 3.66-meter long and 0.9-meter wide instrumented walkway
Step time in second5 minutesusing GAITRite with a 3.66-meter long and 0.9-meter wide instrumented walkway
Double limb support time in second5 minutesusing GAITRite with a 3.66-meter long and 0.9-meter wide instrumented walkway
Modified Hoehn and Yahr staging5 minutesscale range 0-5. The scale was originally described in 1967 and included stages 1 through 5. It has since been modified with the addition of stages 1.5 and 2.5 to account for the intermediate course of Parkinson disease.
Time up and go test in second2 minutesThe Timed Up and Go test (TUG) is a simple test used to assess a person's mobility

Secondary

MeasureTime frameDescription
Cognitive performance10 minutesThe cognitive performance was described as a composite score (%) = accuracy (%)/reaction time (ms) \*100
Dual-task interference10 minutesThe effect of the dual-task was calculated as the difference between single-task and dual-task performance expressed as a percentage of single-task performance
Adverse event5 minutesany complain from study subject

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026